These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
    Author: Moesgaard Nielsen V, Vinther B, Illum P.
    Journal: Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306.
    Abstract:
    The clinical effect and the side effects of a new steroid, Fluocortin butylester (FCB) in the topical treatment of hay fever was studied in a double-blind trial. The drug was administered by inhalation of a fine powder through a special inhalator (Rhinolator). The material comprised 31 patients, and the treatment period was three weeks. There was a highly significant difference in favour of FCB compared with placebo as regards the nasal symptoms blockage and discharge. Side effects were few and mild.
    [Abstract] [Full Text] [Related] [New Search]